Assessing the current treatment of atopic dermatitis: Unmet needs
- 1 April 2017
- journal article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 139 (4) , S47-S48
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelinesJournal of Allergy and Clinical Immunology, 2017
- The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapiesJournal of Allergy and Clinical Immunology, 2017
- Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go?Journal of Allergy and Clinical Immunology, 2017
- Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic DisorderJournal of Investigative Dermatology, 2017
- Cellular and molecular immunologic mechanisms in patients with atopic dermatitisJournal of Allergy and Clinical Immunology, 2016
- Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trialThe Lancet, 2016
- Associations of Childhood Eczema Severity: A US Population-Based StudyDermatitis®, 2014
- A Population-Based Survey of Eczema Prevalence in the United StatesDermatitis®, 2007
- In vivo expression of IL-12 and IL-13 in atopic dermatitisJournal of Allergy and Clinical Immunology, 1996
- Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis.Journal of Clinical Investigation, 1994